A First-In-Human Study of LY3985297 in Healthy Participants
Clinical trial NCT06395012 · COMPLETED
Trial details
- NCT number
- NCT06395012
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-07
- Primary completion
- 2025-08-06
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.